Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review

References

• Abbott Laboratories12006aDepakote^® package insertNorth Chicago, IL
   Google Scholar
• Abbott Laboratories12006bDepakote ER^® package insertNorth Chicago, IL
   Google Scholar
• AstraZeneca102006Seroquel^® package insertWilmington, DE
   Google Scholar
• [APA] American Psychiatric Association2000Diagnostic and statistical manual of mental disorder, Fourth Edition-Text RevisionWashington, DCAmerican Psychiatric Association
   Google Scholar
• BowdenCLGitlinMJKeckPE2002Practice Guideline for the treatment of subjects with bipolar disorder (revision)Am J Psychiatry159April Suppl150
   Google Scholar
• Bristol-Myers Squibb102006Abilify^® package insertPrinceton, NJ
   Google Scholar
• BrunelloN2004Mood stabilizers: protecting the mood…protecting the brainJournal of Affective Disorders79Suppl 1S152015121343
   PubMed Web of Science ®Google Scholar
• CaseyDEDanielDGWassefAA2003Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophreniaNeuropsychopharmacology281829212496955
   PubMed Web of Science ®Google Scholar
• CentorrinoFKelleherJPBerryJM2003Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disordersAm J Psychiatry16013485012832255
   PubMed Web of Science ®Google Scholar
• CitromeLCaseyDDanielDG2004Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidonePsychiatric Services55290415001730
   PubMed Web of Science ®Google Scholar
• CitromeLTremeauFWynnPS2004A study of the safety, efficacy, and tolerability of switching from the standard delayed release preparation of divalproex sodium to the extended release formulation in patients with schizophreniaJ Clin Psychopharmacol24255915118478
   PubMed Web of Science ®Google Scholar
• DuttaSZhangYSelnessDS2002Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteersEpilepsy Research4911011948003
   PubMed Web of Science ®Google Scholar
• Eli Lilly and CompanyNov 132006Zyprexa^® package insertIndia-napolis, IN
   Google Scholar
• GlaxoSmithKline92003Eskalith^® package insertResearch Triangle ParkNC
   Google Scholar
• GlaxoSmithKline92006Lamictal^® package insertGreenville, NC
   Google Scholar
• HarwoodAJ2005Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisitedMolecular Psychiatry101172615558078
   PubMed Web of Science ®Google Scholar
• HarwoodAJAgamG2003Search for a common mechanism of mood stabilizersBiochemical Pharmacology661798912826261
   PubMed Web of Science ®Google Scholar
• HirschfeldRMCalabreseJRWeissmanMM2003Screening for bipolar disorder in the communityJ Clin Psychiatry6453912590624
   PubMed Web of Science ®Google Scholar
• HirschfeldRMLewisLVornikLA2003Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorderJ Clin Psychiatry641617412633125
   PubMed Web of Science ®Google Scholar
• HorneRLCunananC2003Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodiumJ Clin Psychopharmacol231768112640219
   PubMed Web of Science ®Google Scholar
• JacksonRSVenkataramanSAtkinsRB2006Efficacy and tolerability of divalproex extended release in psychiatric patientsAnnals of Clinical Psychiatry18273417162629
   PubMedGoogle Scholar
• Janssen102006Risperdal^® package insertTitusville, NJ
   Google Scholar
• JuddLLAkiskalHSSchettlerPJ2002The long-term natural history of the weekly symptomatic status of bipolar I disorderArch Gen Psychiatry59530712044195
   PubMed Web of Science ®Google Scholar
• KeckPEPerlisRHOttoMW122004The expert consensus guideline series: treatment of bipolar disorder 2004Postgraduate Medicine1116
   Google Scholar
• LehmanAFLiebermanJADixonLB2004Practice guideline for the treatment of patients with schizophrenia, second editionAm J Psych161156
   PubMed Web of Science ®Google Scholar
• LongoLP2005Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodiumAm J Psychiatry1621548916055790
   PubMed Web of Science ®Google Scholar
• LoscherW2002Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsyCNS Drugs166699412269861
   PubMed Web of Science ®Google Scholar
• McElroySL2004Diagnosing and treating comorbid (complicated) bipolar disorderJ Clin Psychiatry65Suppl 15354415554795
   PubMed Web of Science ®Google Scholar
• MinirthFBVealV2005Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended releaseJ Clin Psychopharmacol259910115643111
   PubMed Web of Science ®Google Scholar
• OwensMJNemeroffCB2003Pharmacology of valproatePsychopharmacology Bulletin37Suppl 2S1724
   PubMedGoogle Scholar
• Pfizer52005Geodon^® package insertNew York, NY
   Google Scholar
• SalloumIMCorneliusJRDaleyDC2005Efficacy of valproate maintenance in patients with bipolar disorder and alcoholismArch Gen Psychiatry62374515630071
   PubMed Web of Science ®Google Scholar
• ShaltielGShamirGShapiroJ2004Valproate decreases inositol biosynthesisBiological Psychiatry568687415576064
   PubMed Web of Science ®Google Scholar
• Shire US Inc.122004Equetro^® package insertWayne, PA
   Google Scholar
• Solvay Pharmaceuticals12006Lithobid^® package insertMarietta, GA
   Google Scholar
• StonerSCDubisarBMLeaJW2004Extended-release divalproex sodium for mood stabilizationPharmacotherapy2411475315460175
   PubMed Web of Science ®Google Scholar
• SuppesTDennehyEBHirschfeldRM2005The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderJ Clin Psychiatry668708616013903
   PubMed Web of Science ®Google Scholar
• TaylorMJGoodwinGM2006Long-term prophylaxis in bipolar disorderCNS Drugs203031016599648
   PubMed Web of Science ®Google Scholar
• TothM2005The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproateMedical Hypotheses642677215607553
   PubMed Web of Science ®Google Scholar
• ZarateCATohenMNarendranR1999The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology studyJ Clin Psychiatry60232610221283
   PubMed Web of Science ®Google Scholar